Total Payments
$3,475
2023 Payments
$931.53
Companies
28
Transactions
210
Medicare Patients
1,041
Medicare Billing
$94,568
Payment Breakdown by Category
Food & Beverage$3,475 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,475 | 210 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $464.94 | 28 | $0 (2023) |
| Novo Nordisk Inc | $446.29 | 39 | $0 (2023) |
| GlaxoSmithKline, LLC. | $334.09 | 10 | $0 (2023) |
| Biohaven Pharmaceutical Holding Company Ltd. | $298.29 | 24 | $0 (2022) |
| Lilly USA, LLC | $295.65 | 21 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $227.60 | 15 | $0 (2023) |
| Corcept Therapeutics | $206.22 | 6 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $187.63 | 12 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $181.81 | 13 | $0 (2023) |
| Biohaven Pharmaceuticals, Inc. | $152.63 | 8 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $931.53 | 53 | ABBVIE INC. ($212.69) |
| 2022 | $1,742 | 111 | Biohaven Pharmaceutical Holding Company Ltd. ($298.29) |
| 2021 | $802.38 | 46 | Takeda Pharmaceuticals U.S.A., Inc. ($152.81) |
All Payment Transactions
210 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/22/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: Diabetes | ||||||
| 08/16/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $22.14 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/28/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $9.46 | General |
| Category: Diabetes | ||||||
| 07/26/2023 | Lilly USA, LLC | EMGALITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $7.71 | General |
| Category: Neuroscience | ||||||
| 07/25/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $24.35 | General |
| Category: NEUROSCIENCE | ||||||
| 07/25/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $6.83 | General |
| Category: Diabetes | ||||||
| 07/20/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $17.36 | General |
| Category: INSOMNIA | ||||||
| 07/19/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.50 | General |
| Category: NEUROSCIENCE | ||||||
| 07/17/2023 | Supernus Pharmaceuticals, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $24.91 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 07/13/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $32.92 | General |
| Category: NEUROSCIENCE | ||||||
| 07/10/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.68 | General |
| Category: Diabetes | ||||||
| 07/07/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.85 | General |
| Category: NEUROSCIENCE | ||||||
| 06/28/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $6.72 | General |
| Category: Diabetes | ||||||
| 06/20/2023 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $21.90 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 06/14/2023 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $27.49 | General |
| Category: NEUROSCIENCE | ||||||
| 06/12/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/01/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.58 | General |
| Category: NEUROSCIENCE | ||||||
| 05/31/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: NEUROSCIENCE | ||||||
| 05/22/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.26 | General |
| Category: Inflammation | ||||||
| 05/18/2023 | Antares Pharma, Inc. | NOCDURNA (Drug), XYOSTED, TLANDO | Food and Beverage | In-kind items and services | $23.84 | General |
| Category: NOCTURIA DUE TO NOCTURNAL POLYURIA IN ADULTS | ||||||
| 05/17/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $6.11 | General |
| Category: Diabetes | ||||||
| 05/09/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $21.71 | General |
| Category: Diabetes | ||||||
| 05/02/2023 | Baxter Healthcare | Hillrom - Life 2000 Ventilation System (Device) | Food and Beverage | In-kind items and services | $18.65 | General |
| Category: Airway Clearance Device | ||||||
| 04/28/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/24/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $27.44 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 271 | 433 | $58,380 | $23,698 |
| 2022 | 8 | 447 | 677 | $84,087 | $41,071 |
| 2021 | 6 | 294 | 397 | $51,265 | $27,294 |
| 2020 | 1 | 29 | 47 | $11,844 | $2,505 |
Total Patients
1,041
Total Services
1,554
Medicare Billing
$94,568
Procedure Codes
19
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 189 | 344 | $55,040 | $22,702 | 41.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 14 | 14 | $2,310 | $539.91 | 23.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 41 | 47 | $470.00 | $394.80 | 84.0% |
| 81003 | Automated urinalysis test | Office | 2023 | 27 | 28 | $560.00 | $61.60 | 11.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 270 | 448 | $71,680 | $35,854 | 50.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 43 | 43 | $7,095 | $3,087 | 43.5% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2022 | 20 | 20 | $1,500 | $1,019 | 67.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 14 | 14 | $1,750 | $725.85 | 41.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 54 | 61 | $610.00 | $180.69 | 29.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 11 | 12 | $600.00 | $110.35 | 18.4% |
| 81003 | Automated urinalysis test | Office | 2022 | 21 | 23 | $460.00 | $51.13 | 11.1% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 14 | 56 | $392.00 | $42.97 | 11.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 148 | 239 | $38,240 | $21,444 | 56.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 45 | 49 | $6,125 | $2,787 | 45.5% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 31 | 31 | $5,100 | $2,268 | 44.5% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 12 | 12 | $900.00 | $615.72 | 68.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 37 | 42 | $420.00 | $126.00 | 30.0% |
| 81003 | Automated urinalysis test | Office | 2021 | 21 | 24 | $480.00 | $54.00 | 11.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 29 | 47 | $11,844 | $2,505 | 21.1% |
About Timothy Wright, FNP
Timothy Wright, FNP is a Registered Nurse First Assistant healthcare provider based in Fresno, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1164512240.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Timothy Wright, FNP has received a total of $3,475 in payments from pharmaceutical and medical device companies, with $931.53 received in 2023. These payments were reported across 210 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($3,475).
As a Medicare-enrolled provider, Wright has provided services to 1,041 Medicare beneficiaries, totaling 1,554 services with total Medicare billing of $94,568. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Ad
Practice Information
- Specialty Registered Nurse First Assistant
- Other Specialties Nurse Practitioner
- Location Fresno, CA
- Active Since 10/13/2006
- Last Updated 05/13/2024
- Taxonomy Code 163WR0006X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1164512240
Products in Payments
- NURTEC ODT (Drug) $450.92
- TRELEGY ELLIPTA (Drug) $313.26
- Rybelsus (Drug) $291.29
- TRINTELLIX (Drug) $227.60
- Korlym (Drug) $206.22
- FARXIGA (Drug) $187.63
- EMGALITY (Drug) $187.51
- JARDIANCE (Drug) $171.16
- QULIPTA (Drug) $166.39
- UBRELVY (Drug) $149.59
- Ozempic (Drug) $143.64
- VRAYLAR (Drug) $134.02
- MOUNJARO (Drug) $108.14
- NOCDURNA (Drug) $94.49
- Xhance (Drug) $72.20
- QUVIVIQ (Drug) $56.45
- Vascepa (Drug) $52.90
- XYOSTED (Drug) $47.72
- REXULTI (Drug) $40.72
- Dayvigo (Drug) $38.74
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Registered Nurse First Assistant Doctors in Fresno
Ms. Veronica Ciaccio, Rnfa, RNFA
Registered Nurse First Assistant — Payments: $19.75
Registered Nurse First Assistant $19.75
Irene Cortez, Rnfa, RNFA
Registered Nurse First Assistant
Registered Nurse First Assistant
Mrs. Kathleen Reid, Rnfa, RNFA
Registered Nurse First Assistant
Registered Nurse First Assistant
Dr. Julie Carlock, Rnfa, RNFA
Registered Nurse First Assistant
Registered Nurse First Assistant
Shelly Hill, Rn, RN
Registered Nurse First Assistant
Registered Nurse First Assistant
Nichole Berumen
Registered Nurse First Assistant
Registered Nurse First Assistant